TGAM
ABBV icon

TBH Global Asset Management’s AbbVie ABBV Stock Holding History

TBH Global Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Sell
7,978
-372
-4% -$82.5K 0.35% 70
2025
Q4 		$1.91M Buy
8,350
+493
+6% +$112K 0.32% 68
2025
Q3 		$1.82M Sell
7,857
-129
-2% -$26.3K 0.36% 72
2025
Q2 		$1.48M Buy
7,986
+220
+3% +$40.9K 0.32% 59
2025
Q1 		$1.63M Buy
7,766
+292
+4% +$56.8K 0.31% 53
2024
Q4 		$1.33M Buy
7,474
+399
+6% +$73.4K 0.31% 78
2024
Q3 		$1.4M Sell
7,075
-180
-2% -$33.6K 0.3% 79
2024
Q2 		$1.24M Sell
7,255
-391
-5% -$64.8K 0.28% 82
2024
Q1 		$1.39M Buy
7,646
+452
+6% +$77.9K 0.28% 66
2023
Q4 		$1.11M Sell
7,194
-341
-5% -$49.7K 0.23% 78
2023
Q3 		$1.12M Buy
7,535
+9
+0.1% +$1.32K 0.22% 83
2023
Q2 		$1.01M Sell
7,526
-14
-0.2% -$2.05K 0.2% 85
2023
Q1 		$1.2M Buy
7,540
+262
+4% +$40.1K 0.26% 73
2022
Q4 		$1.18M Buy
7,278
+88
+1% +$13.5K 0.29% 68
2022
Q3 		$965K Buy
7,190
+10
+0.1% +$1.44K 0.25% 68
2022
Q2 		$1.1M Buy
7,180
+172
+2% +$26.3K 0.26% 70
2022
Q1 		$1.14M Buy
7,008
+8
+0.1% +$1.16K 0.24% 75
2021
Q4 		$948K Buy
7,000
+58
+0.8% +$6.85K 0.2% 84
2021
Q3 		$749K Buy
6,942
+123
+2% +$14.1K 0.17% 93
2021
Q2 		$768K Buy
6,819
+6
+0.1% +$676 0.18% 92
2021
Q1 		$737K Buy
6,813
+141
+2% +$15.1K 0.19% 90
2020
Q4 		$715K Sell
6,672
-551
-8% -$53K 0.22% 85
2020
Q3 		$633K Buy
7,223
+905
+14% +$85.2K 0.22% 84
2020
Q2 		$620K Buy
6,318
+4
+0.1% +$352 0.25% 74
2020
Q1 		$481K Buy
6,314
+3
+0% +$256 0.2% 81
2019
Q4 		$559K Buy
+6,311
New +$524K 0.17% 88

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TBH Global Asset Management's ABBV Position: Q1 2026 in Review

TBH Global Asset Management reduced its AbbVie (ABBV) stake by 4.5% in Q1 2026, selling an estimated $82.5K and leaving 7,978 shares worth $1.74M. The position accounts for 0.35% of the portfolio, ranked #70.

TBH Global Asset Management first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.91M in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • TBH Global Asset Management held 7,978 shares of AbbVie worth $1.74M as of Q1 2026.
  • TBH Global Asset Management sold 372 AbbVie shares in Q1 2026, an estimated $82.5K.
  • AbbVie made up 0.35% of TBH Global Asset Management's portfolio in Q1 2026, its #70 holding.
  • TBH Global Asset Management first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • TBH Global Asset Management's AbbVie position peaked at $1.91M in Q4 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on TBH Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.